QUALCOMM Incorporated
-0.32 %
-29.74 %
Yet to be announced
Company Overview
QUALCOMM Incorporated engages in the development and commercialization of foundational technologies for the wireless industry. The company operates through three segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL) and Qualcomm Strategic Initiatives (QSI) The QCT segment develops and supplies integrated circuits and system software based on 3G/4G/5G and other technologies for use in wireless voice and data communications. The QTL segment grants licenses or provides rights to use portions of its intellectual property portfolio.
Revenue Sources
PassBased on review of QUALCOMM's financial statements and business operations, the company's primary revenue streams come from technology licensing and semiconductor product sales. These core business activities involve the exchange of tangible products and services and do not constitute prohibited activities under Islamic finance principles.
Reliance on Interest
| Reporting Date | Total Revenue | Total Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| March 30, 2025 | $10.98b | $8.02b | - | $163.0m | 0.00% | 2.03% |
| Dec. 29, 2024 | $11.67b | $8.28b | - | $163.0m | 0.00% | 1.97% |
| Sept. 29, 2024 | $10.24b | $7.84b | - | $179.0m | 0.00% | 2.28% |
| June 23, 2024 | $9.39b | $7.34b | - | $168.0m | 0.00% | 2.29% |
Analysis of the last four quarters shows that interest expenses represent a relatively small portion of total expenses. The interest expense ratios for the past four quarters have consistently remained below 2.5% of total expenses, indicating that interest-based financing is not a material part of the company's operations.
Operational Ethics
PassWhile QUALCOMM maintains business operations in various global markets, including China, there is no clear evidence of material ongoing collaboration with the Chinese Communist Party or other entities involved in human rights violations. The company has no R&D centers or significant operations in Israel.
Comments